Skip to main content

Flublok Quadrivalent FDA Approval History

Last updated by Judith Stewart, BPharm on Oct 28, 2020.

FDA Approved: Yes (First approved October 7, 2016)
Brand name: Flublok Quadrivalent
Generic name: influenza virus vaccine, inactivated
Dosage form: Injection
Company: Protein Sciences Corp.
Treatment for: Influenza Prophylaxis

Flublok Quadrivalent is an influenza virus vaccine indicated for active immunization against seasonal influenza in adults 18 years of age and older .

Development timeline for Flublok Quadrivalent

Oct 11, 2016Approval FDA Approves Flublok Quadrivalent Influenza Vaccine
Jun 23, 2016Approval FDA Approved Longer Shelf Life for the Game Changer, Flublok Influenza Vaccine
Oct 29, 2014Approval Flublok Influenza Vaccine Now Approved for Adults Ages 18 and Older
Jan 16, 2013Approval FDA Approves Flublok - New Seasonal Influenza Vaccine Made Using Novel Technology

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.